Loading
Latest filing published 22 Jan 2020 for Genix Pharmaceucticals Corporation.
No signal scores available.
All filings by Kevin Bottomley on record concern Genix Pharmaceucticals Corporation. Between 1 August 2019 and 22 January 2020, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €276. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2020 alone, the filings show 1 purchase and no sales.
Most recently, on 22 January 2020, the filings show a transaction in Genix Pharmaceucticals Corporation. The latest purchase dates back some time: it was published 2,469 days ago, on 22 January 2020. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations